107411-26-7Relevant articles and documents
Enantioselective hydroarylation or hydroalkenylation of benzo[b]thiophene 1,1-dioxides with organoboranes
Hu, Fangdong,Jia, Jie,Li, Ximing,Xia, Ying
supporting information, p. 896 - 901 (2021/02/01)
An efficient protocol for the asymmetric hydroarylation and hydroalkenylation of benzo[b]thiophene 1,1-dioxides with organoboranes has been developed. The combination of a rhodium(I) precatalyst and a chiral diene ligand constitutes the catalytic system, which enables the facile synthesis of 2,3-dihydrobenzo[b]thiophene 1,1-dioxides in good yields with high enantioselectivities. The merging of this asymmetric hydroarylation with the downstream alkylations delivers 2,3-dihydrobenzo[b]thiophene 1,1-dioxides that contain two continuous quaternary stereocenters with high enantioselectivities in a diastereodivergent manner.
MATERIAL FOR PHOTOELECTRIC CONVERSION ELEMENT FOR USE IN IMAGING ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT INCLUDING SAME
-
Paragraph 0092, (2019/01/22)
本發明係有關一種包含下述式(1)表示之化合物的攝像元件用光電變換元件用材料。該材料可提供防止電洞或電子洩漏之特性、電洞或電子傳輸特性、對製程溫度之耐熱性及可見光透明性等優異之光電變換元件。 The present invention provides a material for photoelectric conversion element for use in imaging element contain a compound represented by the following formula (1). The material can provide a photoelectric conversion element excellent in hole or electron leak prevention property, hole or electron transporting property, heat resistance against process temperature, visible light transparency and the like. (In the formula (1), R1and R2independently represent a substituted or unsubstituted heterocyclic condensed aromatic group).
INHIBITORS OF THE KYNURENINE PATHWAY
-
, (2014/12/12)
The present application provides novel inhibitors of indoleamine 2,3-dioxygenase-1 and/or indoleamine 2,3-dioxygenase-2 and/or tryptophan 2,3-dioxygenase, metabolites thereof, and phannaceutically acceptable salts or prodrugs thereof. Also provided are methods for preparing these compounds. A therapeutically effective amount of one or more of the compounds of formula (I) is useful in treating diseases resulting from dysregulation of the kynurenine pathway. Compounds of formula (I) act by inhibiting the enzymatic activity or expression of indoleamine 2,3-dioxygenase-1 and/or indoleamine 2,3-dioxygenase-2 and/or tryptophan 2,3-dioxygenase.